Stock Events

Stock Events

Rubius Therapeutics 

$0.06
20
+$0+2.7% Friday 20:49

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
5.15M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

8MayExpected
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
-0.61
-0.49
-0.36
-0.24
Expected EPS
-0.24
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
-179.67MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RUBY. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Health Technology
Biotechnology
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Pablo Cagnoni
Employees
213
Country
US
ISIN
US78116T1034
WKN
000A2JQ3H

Listings

0 Comments

Share your thoughts

FAQ

What is Rubius Therapeutics stock price today?▼
The current price of RUBY is $0.06 USD — it has increased by +2.7% in the past 24 hours. Watch Rubius Therapeutics stock price performance more closely on the chart.
What is Rubius Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Rubius Therapeutics stocks are traded under the ticker RUBY.
What is Rubius Therapeutics market cap?▼
Today Rubius Therapeutics has the market capitalization of 5.15M
What is Rubius Therapeutics revenue for the last year?▼
Rubius Therapeutics revenue for the last year amounts to 0 USD.
What is Rubius Therapeutics net income for the last year?▼
RUBY net income for the last year is -179.67M USD.
How many employees does Rubius Therapeutics have?▼
As of April 02, 2026, the company has 213 employees.
In which sector is Rubius Therapeutics located?▼
Rubius Therapeutics operates in the Professional, Scientific, and Technical Services sector.
When did Rubius Therapeutics complete a stock split?▼
Rubius Therapeutics has not had any recent stock splits.
Where is Rubius Therapeutics headquartered?▼
Rubius Therapeutics is headquartered in Cambridge, US.